LEGN

Legend Biotech Corp ADR

Sep 17 • 04:00PM ET

34.47

+0.13 0.38 %

Healthcare • Biotechnology • USA • NASD

Peers: GILD CRSP BMY BLUE ALLO EDIT FATE CLLS NTLA SGMO

| Held by: IBB IEMG EEMV MCHI EEM IXUS FBCG SPEM CANC GNOM

Index	-	P/E	-	EPS (ttm)	-1.77	Insider Own	2.06%	Shs Outstand	184.57M	Perf Week	2.99%
Market Cap	6.36B	Forward P/E	52.92	EPS next Y	0.65	Insider Trans	0.00%	Shs Float	180.77M	Perf Month	-7.96%
Enterprise Value	5.78B	PEG	-	EPS next Q	-0.04	Inst Own	44.91%	Short Float	4.35%	Perf Quarter	-0.66%
Income	-325.92M	P/S	7.97	EPS this Y	-24.66%	Inst Trans	-3.19%	Short Ratio	6.14	Perf Half Y	-9.00%
Sales	798.01M	P/B	6.14	EPS next Y	208.87%	ROA	-18.69%	Short Interest	7.86M	Perf YTD	5.93%
Book/sh	5.61	P/C	6.57	EPS next 5Y	-	ROE	-29.70%	52W High	52.15 -33.90%	Perf Year	-31.48%
Cash/sh	5.24	P/FCF	-	EPS past 3/5Y	30.38% 0.83%	ROIC	-22.99%	52W Low	27.34 26.08%	Perf 3Y	-22.33%
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	108.79% 61.35%	Gross Margin	59.58%	Volatility	3.50% 3.39%	Perf 5Y	12.50%
Dividend TTM	-	EV/Sales	7.25	EPS Y/Y TTM	-13.20%	Oper. Margin	-27.87%	ATR (14)	1.28	Perf 10Y	-
Dividend Ex-Date	-	Quick Ratio	4.57	Sales Y/Y TTM	75.01%	Profit Margin	-40.84%	RSI (14)	44.93	Recom	1.19
Dividend Gr. 3/5Y	- -	Current Ratio	4.71	EPS Q/Q	-586.04%	SMA20	-0.58%	Beta	0.25	Target Price	75.67
Payout	-	Debt/Eq	0.37	Sales Q/Q	37.22%	SMA50	-8.38%	Rel Volume	0.87	Prev Close	34.34
Employees	2609	LT Debt/Eq	0.37	Earnings	Aug 11 BMO	SMA200	-2.55%	Avg Volume	1.28M	Price	34.47
IPO	Jun 05, 2020	Option/Short	Yes / Yes	EPS/Sales Surpr.	-199.56% 11.40%	Trades		Volume	1,120,883	Change	0.38%

Date	Action	Analyst	Rating Change	Price Target Change
Oct-08-24	Initiated	Redburn Atlantic	Buy	$86
Jun-17-24	Initiated	Truist	Buy	$88
May-24-24	Reiterated	H.C. Wainwright	Buy	$86 → $73
May-23-24	Initiated	Deutsche Bank	Buy	$60
Apr-17-24	Upgrade	Scotiabank	Sector Perform → Sector Outperform	$65
Apr-03-24	Initiated	Cantor Fitzgerald	Overweight	$82
Mar-13-24	Initiated	Raymond James	Outperform	$86
Dec-19-23	Initiated	Scotiabank	Sector Perform
Nov-06-23	Initiated	Goldman	Buy	$90.09
May-25-23	Initiated	William Blair	Mkt Perform	$64
May-22-23	Initiated	Daiwa Securities	Buy
Mar-29-23	Initiated	H.C. Wainwright	Buy	$66
Mar-24-23	Initiated	RBC Capital Mkts	Outperform	$73
Dec-06-22	Initiated	UBS	Buy	$66
Nov-02-22	Initiated	Evercore ISI	Outperform
Nov-01-22	Initiated	Cowen	Outperform
Oct-31-22	Initiated	Guggenheim	Neutral
Jun-17-22	Initiated	BMO Capital Markets	Outperform	$77
Mar-15-22	Initiated	Barclays	Overweight	$53
Jan-31-22	Upgrade	Morgan Stanley	Equal-Weight → Overweight	$51

Show Previous Ratings

Aug-26-25 08:00AM	Legend Biotech to Participate in the Morgan Stanley Global Healthcare Conference (GlobeNewswire)
Aug-22-25 11:57PM	RBC Capital Lifts PT on Legend Biotech Corporation (LEGN) to $77 From $75 (Insider Monkey)
05:30AM	China's rise in biotech to potentially lower healthcare costs, life science investor says (South China Morning Post)
Aug-18-25 08:00AM	Legend Biotech Appoints Carlos Santos as Chief Financial Officer (GlobeNewswire)
Aug-12-25 07:22AM	Company News for Aug 12, 2025 (Zacks)
03:03AM	Loading…
03:03AM	Legend Biotech Corp (LEGN) Q2 2025 Earnings Call Highlights: Record CARVYKTI Sales and ... (GuruFocus.com)
Aug-11-25 10:53AM	Key Inflation Data in Focus (Zacks)
10:12AM	Pre-Markets in Green, Inflation Data, Retail Sales, Q2 Earnings This Week (Zacks)
07:00AM	Legend Biotech Reports Second Quarter 2025 Results and Recent Highlights (GlobeNewswire)
Aug-08-25 09:17AM	Legend Biotech Corp (LEGN) Q2 2025 Earnings Report Preview: What to Expect (GuruFocus.com)
Jul-28-25 08:00AM	Legend Biotech to Host Investor Conference Call on Second Quarter 2025 Results (GlobeNewswire)
Jul-18-25 07:24AM	Legend Biotech (LEGN) Surges 6.0%: Is This an Indication of Further Gains? (Zacks)
Jul-13-25 05:00PM	China Biotechs Stunning Advance Is Changing the Worlds Drug Pipeline (Bloomberg)
Jul-06-25 04:15AM	H.C. Wainwright Maintains a Buy on Legend Biotech (LEGN) With a $75 Price Target (Insider Monkey)
Jun-20-25 04:08PM	The FDA Shake-Up Continues, And Could Impact Genetic Medicines (Investor's Business Daily)
10:45AM	Loading…
Jun-03-25 10:45AM	Legend Biotech Unveils Groundbreaking 5-Year Survival Data for CARVYKTI in Multiple Myeloma at 2025 ASCO Annual Meeting (GlobeNewswire)
May-22-25 05:15PM	Legend Biotech Announces New Oncologic & Hematologic Therapeutic Developments at ASCO, EHA, and ASGCT (GlobeNewswire)
May-19-25 08:00AM	Legend Biotech to Host Investor Event During the 2025 American Society of Clinical Oncology (ASCO) Annual Meeting (GlobeNewswire)
May-14-25 09:18AM	Morning Movers: UnitedHealth sinks following CEO exit and outlook suspension (TipRanks) -10.55%
03:06AM	Legend Biotech Corp (LEGN) Q1 2025 Earnings Call Highlights: Record Growth in CARVYKTI Sales ... (GuruFocus.com)
12:24AM	Q1 2025 Legend Biotech Corp Earnings Call (Thomson Reuters StreetEvents)
May-13-25 07:00AM	Legend Biotech Reports First Quarter 2025 Results and Recent Highlights (GlobeNewswire)
May-12-25 09:20AM	What To Expect From Legend Biotech Corp (LEGN) Q1 2025 Earnings (GuruFocus.com)
May-03-25 04:51AM	The Play On Legend Biotech (Seeking Alpha)
May-02-25 12:00PM	What Makes Legend Biotech (LEGN) a New Buy Stock (Zacks)
09:55AM	Wall Street Analysts Think Legend Biotech (LEGN) Could Surge 135.16%: Read This Before Placing a Bet (Zacks)
Apr-29-25 08:00AM	Legend Biotech to Host Investor Conference Call on First Quarter 2025 Results (GlobeNewswire)
Apr-24-25 06:53AM	Legend Biotech Corporation (LEGN): Among Takeover Rumors Hedge Funds Are Buying (Insider Monkey)
Apr-16-25 09:53AM	Legend Biotech (LEGN) Moves 5.1% Higher: Will This Strength Last? (Zacks)
Apr-11-25 12:30AM	Harbor Health Care ETF Q4 2024 Commentary (Seeking Alpha)
05:53AM	Loading…
Apr-09-25 05:53AM	Pacira (PCRX) Surges 14.7%: Is This an Indication of Further Gains? (Zacks)
Apr-01-25 11:50AM	Biotech stocks slide as Marks resignation seen being negative for sector (TipRanks) -7.10%
Mar-12-25 03:02AM	Legend Biotech Corp (LEGN) Q4 2024 Earnings Call Highlights: Record CARVYKTI Sales and ... (GuruFocus.com)
01:34AM	Q4 2024 Legend Biotech Corp Earnings Call (Thomson Reuters StreetEvents)
Mar-11-25 09:30AM	Compared to Estimates, Legend Biotech (LEGN) Q4 Earnings: A Look at Key Metrics (Zacks) +9.29%
07:00AM	Legend Biotech Reports Fourth Quarter and Full Year 2024 Results and Recent Highlights (GlobeNewswire)
Feb-25-25 08:00AM	Legend Biotech to Host Investor Conference Call on Fourth Quarter and Full Year 2024 Results (GlobeNewswire)
Feb-23-25 01:29PM	Why Legend Biotech Corporation (LEGN) is the Most Oversold Pharma Stock to Buy According to Analysts (Insider Monkey)
Feb-21-25 09:43AM	Market Concerns Put Pressure on Legend Biotech Corporation (LEGN) Shares (Insider Monkey)
Feb-20-25 12:18PM	Legend Biotech Corporation (LEGN): One of the Most Oversold Healthcare Stocks to Buy Now (Insider Monkey)
Feb-13-25 02:06PM	Is Legend Biotech (LEGN) the Best Mid-Cap Growth Stock to Buy According to Analysts? (Insider Monkey)
Feb-08-25 09:29AM	Why Legend Biotech Corporation (LEGN) Is Among the Best Healthcare Stocks To Buy According to Analysts (Insider Monkey)
Jan-30-25 05:01PM	Heres Why Legend Biotech Corporation (LEGN) Will Double in 2025 (Insider Monkey)
Jan-17-25 11:04AM	Legend Biotech Corporation (LEGN): The Biotech Stock with Biggest Upside Potential (Insider Monkey)
Dec-19-24 08:01AM	Legend Biotech to Present at the 43rd Annual J.P. Morgan Healthcare Conference (GlobeNewswire)
Dec-11-24 07:22AM	Legend Biotechs CARVYKTI® Boosts Myeloma Treatment Success (TipRanks) -5.44%
Dec-09-24 07:35PM	CARVYKTI Significantly Improved Minimal Residual Disease Negativity Compared to Standard of Care for Patients with Relapsed or Refractory Multiple Myeloma (GlobeNewswire) -8.96%
04:22PM	Arcellx And Legend Bio Trade Jabs In Multiple Myeloma. But Only One Pulls Ahead. (Investor's Business Daily)
Nov-27-24 10:02AM	Why Is Legend Biotech Corp. (LEGN) Among the Best Up and Coming Stocks to Buy According to Analysts? (Insider Monkey)
Nov-22-24 07:31AM	Legend Biotech Corp. (LEGN): Among the NASDAQ Stocks with Biggest Upside Potential According to Analysts (Insider Monkey)
Nov-21-24 05:28PM	Why Is Legend Biotech Corporation (LEGN) Among the Worst Performing Biotech Stocks in 2024? (Insider Monkey)
Nov-13-24 03:28AM	Q3 2024 Legend Biotech Corp Earnings Call (Thomson Reuters StreetEvents)
02:07AM	Legend Biotech Corp (LEGN) Q3 2024 Earnings Call Highlights: CARVYKTI's Impressive Growth Amid ... (GuruFocus.com)
Nov-12-24 09:30AM	Legend Biotech (LEGN) Reports Q3 Earnings: What Key Metrics Have to Say (Zacks)
07:00AM	Legend Biotech Reports Third Quarter 2024 Results and Recent Highlights (GlobeNewswire)
Nov-11-24 09:55AM	Legend Biotech (LEGN) May Find a Bottom Soon, Here's Why You Should Buy the Stock Now (Zacks)
07:04AM	Legend Biotech Corp (LEGN) Q3 2024 Earnings Report Preview: What to Look For (GuruFocus.com)
Nov-07-24 07:30AM	Legend Biotech to Host Investor Event During the 66th American Society of Hematology (ASH) Annual Meeting and Exposition (GlobeNewswire)
Nov-05-24 09:10AM	Legend Biotech to Unveil Minimal Residual Disease Data from Landmark CARTITUDE-4 Trial in Multiple Myeloma (GlobeNewswire)
Nov-04-24 07:30AM	Legend Biotech Appoints Alan Bash as President of CARVYKTI (GlobeNewswire)
Oct-24-24 09:55AM	Wall Street Analysts Believe Legend Biotech (LEGN) Could Rally 90.83%: Here's is How to Trade (Zacks)
08:00AM	Legend Biotech to Host Investor Conference Call on Third Quarter 2024 Results (GlobeNewswire)
Oct-16-24 03:45PM	Is Legend Biotech Corporation (LEGN) the Most Promising Biotech Stock According to Hedge Funds? (Insider Monkey)
Oct-03-24 07:30AM	Legend Biotech to Establish New, State-of-the-Art Cell Therapy Research and Development Facility in Philadelphia (GlobeNewswire)
Sep-30-24 04:11PM	Legend Biotech Reverses After J&J-Tied Cancer Drug Cuts Risk Of Death By 45% (Investor's Business Daily)
09:46AM	Legend Biotech Rises After J&J-Tied Cancer Drug Cuts Risk Of Death By 45% (Investor's Business Daily)
Sep-27-24 04:35PM	CARVYKTI is the First and Only Cell Therapy to Significantly Extend Overall Survival Compared to Standard of Care in Patients with Multiple Myeloma as Early as Second Line (GlobeNewswire) +5.17%
04:30PM	Legend Biotech's J&J-Partnered Drug Cut The Risk Of Death By 45% In Multiple Myeloma (Investor's Business Daily)
Sep-24-24 09:00AM	Multiply Labs Announces a Collaboration on Automating Cell Therapy Manufacturing with Legend Biotech (Business Wire)
Sep-14-24 07:22PM	Legend Biotech Corporation (LEGN): Among Hedge Funds Top Biotech Stock Picks (Insider Monkey)
Sep-12-24 03:34AM	Heres Why TimesSquare Capital Management U.S. Focus Growth Strategy Removed Legend Biotech Corporation (LEGN) from its Portfolio (Insider Monkey)
Sep-03-24 12:01PM	Matthews Emerging Markets Small Companies Fund Boosts Stake in Legend Biotech Corp (GuruFocus.com)
Aug-27-24 10:28AM	GenScript Subsidiary Legend Biotech Achieves Breakthrough with Cilta-cel Approval in China, Offering New Hope for Multiple Myeloma Patients (PR Newswire)
Aug-20-24 08:00AM	Legend Biotech to Participate in the Morgan Stanley 22nd Annual Global Healthcare Conference (GlobeNewswire)
Aug-09-24 07:00AM	Legend Biotech Reports Second Quarter 2024 Results and Recent Highlights (GlobeNewswire)
Aug-08-24 04:05PM	Legend Biotech Appoints Peter Salovey, Ph.D., to its Board of Directors (GlobeNewswire)
Jul-29-24 03:24PM	Is Legend Biotech Corporation (LEGN) a Good Growth Stock to Buy? (Insider Monkey)
Jul-26-24 07:00AM	Legend Biotech Announces Preliminary Results for the Six-Months Ended June 30, 2024 (GlobeNewswire)
Jul-15-24 09:17AM	Legend Biotech (LEGN) Up 12% on Reports of Takeover Bid (Zacks)
07:39AM	Legend Biotech (LEGN) Surges 12.1%: Is This an Indication of Further Gains? (Zacks)
Jul-10-24 08:00AM	Legend Biotech to Host Investor Conference Call on Second Quarter 2024 Results (GlobeNewswire)
Jul-02-24 08:00AM	Legend Biotech Announces Positive Overall Survival Results of Landmark Phase 3 CARTITUDE-4 Trial in Multiple Myeloma (GlobeNewswire)
Jun-24-24 08:13AM	Does Legend Biotech (LEGN) Have a Long Runway for Growth? (Insider Monkey)
Jun-20-24 05:26PM	Biotech Advances Propel Oncology Market to $564.5B Amid Youth Cancer Spike (PR Newswire)
Jun-03-24 04:00PM	Legend Biotech Shares Data on the Earliest Use to Date of CARVYKTI in the Treatment of Multiple Myeloma and Important Subgroup Analyses at ASCO and EHA (Business Wire)
May-29-24 08:00AM	Legend Biotech to Participate in the Jefferies Global Healthcare Conference (Business Wire)
May-23-24 05:00PM	Legend Biotech to Highlight Leadership in CAR-T Cell Therapy for Patients with Multiple Myeloma at ASCO and EHA (Business Wire) -7.28%
May-15-24 08:19AM	Legend Biotech Corporation (NASDAQ:LEGN) Q1 2024 Earnings Call Transcript (Insider Monkey)
May-14-24 09:23AM	HC Wainwright Adjusts Price Target on Legend Biotech to $86 From $87, Keeps Buy Rating (MT Newswires)
06:54AM	RBC Adjusts Price Target on Legend Biotech to $86 From $85 on Model Updates, Maintains Outperform Rating (MT Newswires)
03:01AM	Legend Biotech Corp (LEGN) Q1 2024 Earnings Call Transcript Highlights: Soaring CARVYKTI Sales ... (GuruFocus.com)
12:20AM	Q1 2024 Legend Biotech Corp Earnings Call (Thomson Reuters StreetEvents)
May-13-24 11:53AM	LEGN Stock Earnings: Legend Biotech Beats EPS, Misses Revenue for Q1 2024 (InvestorPlace)
09:24AM	Sector Update: Health Care Stocks Decline Pre-Bell Monday (MT Newswires)
08:57AM	Sector Update: Health Care (MT Newswires)
07:30AM	Legend Biotech Q1 Net Loss Narrows as Revenue Rises; Shares Rise Pre-Bell (MT Newswires)
07:00AM	Legend Biotech Reports First Quarter 2024 Results and Recent Highlights (Business Wire)
May-09-24 08:52AM	Should You Buy Legend Biotech (LEGN) Ahead of Earnings? (Zacks)
Apr-25-24 11:28AM	11 Oversold MidCap Stocks To Buy Now (Insider Monkey)
Apr-22-24 01:37PM	Legend Biotech's Carvykti Gets European Commission Approval for Treatment of Blood Cancer (MT Newswires)

Legend Biotech Corp. is a clinical-stage biopharmaceutical company, which engages in the discovery, development, manufacturing, and commercialization of novel therapies for oncology and other indications. The firm develops advanced cell therapies across a diverse array of technology platforms, including autologous and allogeneic chimeric antigen receptor T-cell, gamma-delta T cell and natural killer cell-based immunotherapy. It operates through the following geographical segments: United States of America, China, and Other. The company was founded in 2014 and is headquartered in Somerset, NJ.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	SEC Form 4
Huang Ying	Officer	Jul 23 '25	Proposed Sale	45.04	15,291	688,723	Jul 23 04:11 PM
Yeung Jessie	Officer	Jul 23 '25	Proposed Sale	45.00	642	28,890	Jul 23 12:00 PM
Casey Patrick John	Director	Jun 26 '25	Proposed Sale	33.23	1,000	33,234	Jun 26 11:21 AM
Huang Ying	Officer	Jun 25 '25	Proposed Sale	33.72	12,119	408,653	Jun 25 10:31 AM
Huang Ying	Officer	Jun 24 '25	Proposed Sale	34.60	11,810	408,600	Jun 24 04:23 PM
Sanders Corazon (Corsee) D.	Director	Jun 24 '25	Proposed Sale	34.37	307	10,552	Jun 24 10:05 AM
Casey Patrick John	Director	Jun 06 '25	Proposed Sale	32.32	1,000	32,320	Jun 06 11:18 AM
Huang Ying	Officer	May 01 '25	Proposed Sale	34.55	6,548	226,233	May 01 11:06 AM
Yeung Jessie	Officer	Mar 25 '25	Proposed Sale	35.28	339	11,959	Mar 25 03:47 PM
Huang Ying	Officer	Mar 25 '25	Proposed Sale	35.28	4,064	143,371	Mar 25 03:41 PM
Sanders Corazon (Corsee) D.	Director	Mar 25 '25	Proposed Sale	36.33	307	11,153	Mar 25 12:15 PM
Macomber Lori	Former Officer	Mar 13 '25	Proposed Sale	37.52	32,632	1,224,285	Mar 13 11:42 AM
Macomber Lori	Former Officer	Jan 10 '25	Proposed Sale	32.19	2,254	72,553	Jan 10 03:14 PM
Huang Ying	Officer	Dec 24 '24	Proposed Sale	32.45	63,061	2,046,512	Dec 26 09:59 AM
Macomber Lori	Officer	Dec 24 '24	Proposed Sale	32.45	189	6,134	Dec 26 09:48 AM
Heyman Tomas J.	Director	Dec 02 '24	Proposed Sale	43.31	4,366	189,080	Dec 02 03:08 PM
Huang Ying	Officer	Sep 25 '24	Proposed Sale	44.10	1,504	66,326	Sep 25 03:30 PM
Macomber Lori	Officer	Sep 20 '24	Proposed Sale	48.91	90,060	4,405,003	Sep 20 04:43 PM
Yau Wai Man Philip	Director	Sep 20 '24	Proposed Sale	51.04	1,946	99,324	Sep 20 10:46 AM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

LEGN

Legend Biotech Corp ADR

Upgrade your FINVIZ experience